IOB - Delayed Quote USD
Teva Pharmaceutical Industries Limited (0LER.IL)
14.25
-0.10
(-0.70%)
At close: April 24 at 7:11:26 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
16,544,000
16,544,000
15,845,000
14,925,000
15,879,000
Cost of Revenue
8,481,000
8,481,000
8,200,000
7,952,000
8,284,000
Gross Profit
8,064,000
8,064,000
7,645,000
6,973,000
7,594,000
Operating Expense
4,700,000
4,700,000
4,451,000
4,283,000
4,495,000
Operating Income
3,364,000
3,364,000
3,194,000
2,690,000
3,099,000
Net Non Operating Interest Income Expense
-1,050,000
-1,050,000
-1,095,000
-991,000
-962,000
Other Income Expense
-3,597,000
-3,597,000
-2,723,000
-4,859,000
-1,480,000
Pretax Income
-1,284,000
-1,284,000
-624,000
-3,163,000
658,000
Tax Provision
676,000
676,000
-7,000
-643,000
211,000
Earnings from Equity Interest Net of Tax
1,000
1,000
2,000
21,000
9,000
Net Income Common Stockholders
-1,639,000
-1,639,000
-559,000
-2,446,000
417,000
Diluted NI Available to Com Stockholders
-1,639,000
-1,639,000
-559,000
-2,446,000
417,000
Basic EPS
-1.45
--
-0.50
-2.12
0.38
Diluted EPS
-1.45
--
-0.50
-2.12
0.38
Basic Average Shares
1,131,000
--
1,119,000
1,110,000
1,102,000
Diluted Average Shares
1,131,000
--
1,119,000
1,110,000
1,107,000
Total Operating Income as Reported
-303,000
-303,000
433,000
-2,197,000
1,716,000
Total Expenses
13,181,000
13,181,000
12,651,000
12,235,000
12,779,000
Net Income from Continuing & Discontinued Operation
-1,639,000
-1,639,000
-559,000
-2,446,000
417,000
Normalized Income
1,137,620
1,137,620
2,122,910
1,420,400
1,409,503.04
Interest Expense
1,002,000
1,002,000
1,029,000
930,000
891,000
Net Interest Income
-1,050,000
-1,050,000
-1,095,000
-991,000
-962,000
EBIT
-282,000
-282,000
405,000
-2,233,000
1,549,000
EBITDA
777,000
777,000
1,558,000
-925,000
2,879,000
Reconciled Cost of Revenue
8,481,000
8,481,000
8,200,000
7,952,000
8,284,000
Reconciled Depreciation
1,059,000
1,059,000
1,153,000
1,308,000
1,330,000
Net Income from Continuing Operation Net Minority Interest
-1,639,000
-1,639,000
-559,000
-2,446,000
417,000
Total Unusual Items Excluding Goodwill
-3,606,000
-3,606,000
-2,709,000
-4,833,000
-1,461,000
Total Unusual Items
-3,606,000
-3,606,000
-2,709,000
-4,833,000
-1,461,000
Normalized EBITDA
4,383,000
4,383,000
4,267,000
3,908,000
4,340,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-829,380
-829,380
-27,090
-966,600
-468,496.96
12/31/2021 - 12/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade